Yuanjin Zhang Selected Research

19-hydroxy-5,8,11,14-eicosatetraenoic acid

2/2021

Investigation of the content differences of arachidonic acid metabolites in a mouse model of breast cancer by using LC-MS/MS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuanjin Zhang Research Topics

Disease

9	Neoplasms (Cancer) 11/2021 - 06/2016
3	Breast Neoplasms (Breast Cancer) 07/2021 - 06/2016
2	Metabolic Diseases (Metabolic Disease) 07/2022 - 01/2022
2	Obesity 01/2022 - 01/2022
2	Peripheral Nervous System Diseases (PNS Diseases) 12/2021 - 01/2021
2	Pain (Aches) 12/2021 - 01/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2021 - 10/2009
2	Inflammation (Inflammations) 06/2020 - 09/2019
2	Ischemic Stroke 01/2020 - 01/2020
2	Stroke (Strokes) 01/2020 - 06/2003
2	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2014
2	Osteosarcoma (Osteogenic Sarcoma) 05/2018 - 06/2014
1	Hypercholesterolemia 07/2022
1	Hyperlipidemias (Hyperlipidemia) 07/2022
1	Fatty Liver 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Insulin Resistance 01/2022
1	Anxiety Disorders (Anxiety Disorder) 12/2021
1	Treatment-Resistant Depressive Disorder 11/2021
1	Non-alcoholic Fatty Liver Disease 11/2021
1	Angina Pectoris 11/2021
1	Supraventricular Tachycardia 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Hypertension (High Blood Pressure) 11/2021
1	Hypersensitivity (Allergy) 03/2021
1	Multiple Abnormalities 03/2021
1	Bites and Stings (Sting) 03/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Erythema 09/2020
1	Prostatic Neoplasms (Prostate Cancer) 07/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Adenocarcinoma of Lung 06/2016
1	Carcinoma (Carcinomatosis) 06/2016
1	Multiple Myeloma 06/2016
1	Transient Ischemic Attack 11/2014

Drug/Important Bio-Agent (IBA)

7	Pharmaceutical PreparationsIBA 07/2022 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 07/2021 - 06/2016
2	Messenger RNA (mRNA)IBA 07/2022 - 06/2016
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 07/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 02/2021 - 06/2014
2	Biological ProductsIBA 07/2019 - 01/2019
1	EnzymesIBA 07/2022
1	LipidsIBA 07/2022
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2022
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Disulfiram (Antabuse)FDA Link 01/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2022
1	OpiumIBA 12/2021
1	Blood Glucose (Blood Sugar)IBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	Dosage Forms (Dosage Form)IBA 12/2021
1	Fluoxetine (Prozac)FDA LinkGeneric 11/2021
1	Olanzapine (Zyprexa)FDA Link 11/2021
1	olanzapine-fluoxetine combination (Symbyax)FDA Link 11/2021
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Verapamil (Calan)FDA LinkGeneric 11/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2021
1	ATP-Binding Cassette Sub-Family B Member 4IBA 07/2021
1	AlkaloidsIBA 03/2021
1	Antiviral Agents (Antivirals)IBA 03/2021
1	aloperineIBA 03/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2021
1	8,9-epoxyeicosatrienoic acidIBA 02/2021
1	19-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 02/2021
1	12-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA 02/2021
1	Arachidonic Acid (Vitamin F)IBA 02/2021
1	EicosanoidsIBA 02/2021
1	TabletsIBA 01/2021
1	NAD (NADH)IBA 01/2021
1	mecobalamin (methylcobalamin)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	Melanins (Melanin)IBA 09/2020
1	SaponinsIBA 06/2020
1	shikoninIBA 09/2019
1	Pyridinolcarbamate (P23)IBA 07/2019
1	ailanthoneIBA 07/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	tyrosine receptor (receptor, tyrosine)IBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 05/2018
1	Cisplatin (Platino)FDA LinkGeneric 05/2018
1	Proteasome InhibitorsIBA 05/2018
1	TriterpenesIBA 03/2017
1	cucurbitacin EIBA 03/2017
1	Glycoproteins (Glycoprotein)IBA 06/2016
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 11/2014
1	ezrinIBA 06/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2009
1	SolutionsIBA 06/2003

Therapy/Procedure

3	Therapeutics 12/2021 - 01/2019
2	Secondary Prevention 01/2020 - 01/2020
1	Immunotherapy 11/2021
1	Skin Care 03/2021
1	Intramuscular Injections 01/2021
1	Castration 07/2019
1	Drug Therapy (Chemotherapy) 05/2018